Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
- - - - - - - 175M
2.73%2.91%12.27x8.93x4.1x9.34x10.56x 33.3B
-.--%-.--%278x1.82x2.93x14.76x17.28x 11.8B
2.72%4.29%9.58x1.41x1.45x5.38x7.03x 4.76B
0.5%0.59%17.44x2.28x1.97x9.83x12.08x 3.39B
0.71%1.02%49.09x2.24x - - - 1.82B
-.--%-.--%27.16x1.81x3.3x11.8x17.2x 1.58B
1.47%1.47%13.1x3.48x1.24x7.39x8.76x 1.32B
1.9%3.04%16.23x1.47x2.06x9.88x15.19x 1.06B
0.46%0.46%32.9x1.15x - - - 992M
1.33%1.53%14.68x1.22x1.03x4.88x6.91x 933M
1.13%1.91%18.05x1.95x - - - 608M
1.72%2.62%26.35x0.64x2.06x9.83x19.53x 467M
Average 1.22% 1.65% 42.90x 2.37x 2.24x 9.23x 12.73x 4.78B
Weighted average by Cap. 1.84% 2.1% 64.99x 5.64x 3.33x 10.10x 11.95x
Veterinary Drugs